Quality of Life and Contact Dermatitis: A Disease-Specific Questionnaire

Ayala, Fabio; Nino, Massimiliano; Fabbrocini, Gabriella; Panariello, Luigia; Balato, Nicola; Foti, Caterina; Tosti, Antonella; Corazza, Monica; Valsecchi, R.; Gola, Massimo; Gallo, Rosella; Guarneri, Fabrizio; Pigatto, Paolo D.; Cristaudo, Antonio; Schena, Donatella; Musumeci, Maria Letizia; Stingeni, Luca; Lisi, Paolo

doi:10.2310/6620.2010.09057

Cited by 28 publications

(21 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In general, age, sex and diagnosis of eczema do not seem to impact QoL outcomes [11]. However, proximity to retirement and diagnosis of atopic dermatitis have correlated with superior patient-reported outcomes in some studies [12], and female gender has previously predicted inferior outcomes [4]. …”

Section: Introductionmentioning

confidence: 99%

Patient Reported Improvement After Patch Testing and Allergen Avoidance Counseling: A Retrospective Analysis

Steuer

Botto

2018

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

IntroductionOur objectives were to assess patient-reported improvement after patch testing at the 2–3-month follow-up visit in patients referred for patch testing with relevant positive patch test reactions at the University of California, San Francisco.MethodsCross-sectional analyses of patients patch tested between 2013 and 2016 who returned for a follow-up visit approximately 2–3 months after patch testing. We examined positive patch test results considered of definite, probable or possible relevance to the patient’s eczematous eruptions. Patients reported improvement after patch testing as a percentage: 0–100%. Patients were categorized into four groups: (1) those that reported no improvement or worsened, (2) those that reported > 0% and ≤ 60% improvement, (3) those that reported > 60% but < 100% improvement and (4) those that reported 100% improvement. Secondary measures included the association of allergens, gender, age and location of the rash.ResultsThe majority (81%) of patients seen at follow-up reported improvement after patch testing. Women reported more improvement than men with statistical significance. Notably, there does not appear to be a statistically significant relationship in patient-reported improvement and age, atopy, strength of a the patient’s positive reactions, number of positive reactions and follow-up time or with potential systemic contact allergens (i.e., balsam of Peru, nickel, chrome and cobalt).ConclusionWe find the large percentage of patients that self-report global benefit from patch testing encouraging, as we believe this to be a powerful measure of disease and symptom activity, as well as quality of life. The gender differences we found contradict the previous literature.

show abstract

Section: Introductionmentioning

confidence: 99%

Patient Reported Improvement After Patch Testing and Allergen Avoidance Counseling: A Retrospective Analysis

Steuer

Botto

2018

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

show abstract

“…However, there are relatively few studies regarding burden of disease in patients with contact dermatitis. Instruments used to assess burden of disease in contact dermatitis include general dermatology instruments and a contact dermatitis‐specific questionnaire (Table ) . Although these instruments are relatively brief (10–20 questions), this is still time consuming in a busy patch test practice.…”

Section: Previous Studiesmentioning

confidence: 99%

“…Lastly, we were surprised that demographic/clinical factors were not associated with greater burden of disease. Other researchers have documented significantly greater burden of disease in patch tested patients or contact dermatitis patients who are female, 4 young, 1 or have involvement of the face, 2 hand, [2][3][4] or foot. 4 However, burden of disease is notoriously difficult to assess, and this is consistent with the psoriasis literature, which shows that measures of clinical severity correlate poorly with measures of burden of disease.…”

Section: Comparing the Very Much Group (Greater Burden Of Disease)mentioning

confidence: 99%

“…Instruments used to assess burden of disease in contact dermatitis include general dermatology instruments and a contact dermatitis-specific questionnaire ( Table 1). [1][2][3][4] Although these instruments are relatively brief (10-20 questions), this is still time consuming in a busy patch test practice. We were interested in assessing burden of disease in patients referred for patch testing using a single question survey.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Single question burden of disease assessment in patients referred for patch testing

Zhang

Warshaw

2018

Int J Dermatology

View full text Add to dashboard Cite

“…Despite pruritus being a guide symptom of ACE, few studies exist about its impact in the QoL of these patients. Ayala et al 15 developed a 20-item questionnaire to explore the QoL of patients with contact eczema, and found itch as one of three aspects strongly associated with a poor QoL.…”

Section: Introductionmentioning

confidence: 99%

Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate

Curto

Carnero

López-Aventín

et al. 2013

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Quality of Life and Contact Dermatitis: A Disease-Specific Questionnaire

Cited by 28 publications

References 0 publications

Patient Reported Improvement After Patch Testing and Allergen Avoidance Counseling: A Retrospective Analysis

Patient Reported Improvement After Patch Testing and Allergen Avoidance Counseling: A Retrospective Analysis

Single question burden of disease assessment in patients referred for patch testing

Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate

Contact Info

Product

Resources

About